Previous Close | 76.02 |
Open | 76.02 |
Bid | 74.98 x 60000 |
Ask | 75.70 x 60000 |
Day's Range | 76.02 - 76.02 |
52 Week Range | 51.50 - 86.50 |
Volume | |
Avg. Volume | 54 |
Market Cap | 10.909B |
Beta (5Y Monthly) | 1.18 |
PE Ratio (TTM) | 27.70 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.18 (0.24%) |
Ex-Dividend Date | Feb 29, 2024 |
1y Target Est | N/A |
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.